a little johnson & johnson story, page-18

Hi Martin,

"I looked at Zosano a bit further, and I reckon it's a competitor. Microneedles and some powder and they started it 8 years ago. So not OBJ tech."

They started "it" over 14 years ago, but does this fact suggest to you that they haven't engaged the services of a technology partner along the way?

"Zosano’s objective is to selectively partner at strategic stages of the development process while retaining select therapeutic programs to develop independently. We want to strategically integrate our proprietary transdermal technology platform into the best possible companies to insure we achieve the most rapid development of therapeutics which utilize our base technology."

"And I don't see anything special in OBJ's 19/6/2007 presentation. If you mean the use of the word "biphasic", then I don't think that's significant. It's just an adjective with multiple potential uses"

I wasn't refering to the use of the word, "biphasic" in referencing the 2007 Presentation, however I did highlight the word in my post as I do believe it is quite significant when used by both Zosano and OBJ to describe proprietary transdermal technology.

"OBJ Limited is pleased to announce the development of what is believed to be the first power-less active drug patch technology. The program was established to determine how OBJ’s expertise in non-contact active drug delivery techniques could be applied to create a new type of drug patch substrate with the ability to drive larger and more complex molecules through the skin. The result is a novel biphasic material, the subject of a recently lodged patent application, that captures thermal energy from the body to create an active drug push."

"And it's got me thinking that maybe GSK are leading OBJ along because GSK is competing too and just pretending to be interested to waste OBJ's time..."

Nonsense!

Zosano may indeed be competition over collaboration to OBJ and partner companies, how it's still worth looking for answers to questions before one can be totally satisfied with this conclusion, Imo.

Q: Which major Pharma are Zosano fast tracking a Ph3 Mab for, and why has no public announcement ever been released about this partnership?

Q: Which leading Vaccine Pharma company is Zosano collaborating with, and why has this information never been publicly released?

Q: As 3M is cited on research and clinical study papers as the developer of the adhesive patch technology incorporated into Zosano's microneedle system, why has no collaboration between 3M and Zosano ever been publicly announced?

Q: Why haven't Zosano announced any public information relating to a keynote presentation on Microneedles held in Ireland last month along with fellow presenters from the University of Queensland and 3M?

Q: As Zosano's website claims that Zosana's patented ZP Patch Technology is supported by over 19 patent families with 20 patents pending, why does a search on the Worldwide patent database provide the following information:

0 results found in the Worldwide database for:
Zosano Pharma Inc as the applicant or inventor

0 results found in the Worldwide database for:
Zosano Pharma Inc in the title or abstract